| Inhibitory effects of quercetin and its main methyl, sulfate, and glucuronic acid conjugates on cytochrome P450 enzymes, and on OATP, BCRP and MRP2 transporters V Mohos, E Fliszár-Nyúl, O Ungvári, K Kuffa, PW Needs, PA Kroon, ... Nutrients 12 (8), 2306, 2020 | 65 | 2020 |
| Inhibitory effects of quercetin and its human and microbial metabolites on xanthine oxidase enzyme V Mohos, A Pánovics, E Fliszár-Nyúl, G Schilli, C Hetényi, P Mladěnka, ... International Journal of Molecular Sciences 20 (11), 2681, 2019 | 50 | 2019 |
| Effects of chrysin and its major conjugated metabolites chrysin-7-sulfate and chrysin-7-glucuronide on cytochrome P450 enzymes and on OATP, P-gp, BCRP, and MRP2 transporters V Mohos, E Fliszár-Nyúl, O Ungvári, É Bakos, K Kuffa, T Bencsik, BZ Zsidó, ... Drug Metabolism and Disposition 48 (10), 1064-1073, 2020 | 48 | 2020 |
| Interactions of casticin, ipriflavone, and resveratrol with serum albumin and their inhibitory effects on CYP2C9 and CYP3A4 enzymes V Mohos, T Bencsik, G Boda, E Fliszár-Nyúl, B Lemli, S Kunsági-Máté, ... Biomedicine & Pharmacotherapy 107, 777-784, 2018 | 39 | 2018 |
| Inhibition of xanthine oxidase-catalyzed xanthine and 6-mercaptopurine oxidation by flavonoid aglycones and some of their conjugates V Mohos, E Fliszár-Nyúl, M Poór International journal of molecular sciences 21 (9), 3256, 2020 | 34 | 2020 |
| Interaction of chrysin and its main conjugated metabolites chrysin-7-sulfate and chrysin-7-glucuronide with serum albumin V Mohos, E Fliszár-Nyúl, G Schilli, C Hetényi, B Lemli, S Kunsági-Máté, ... International Journal of Molecular Sciences 19 (12), 4073, 2018 | 33 | 2018 |
| Pharmacokinetic interaction of diosmetin and silibinin with other drugs: Inhibition of CYP2C9-mediated biotransformation and displacement from serum albumin M Poór, G Boda, V Mohos, M Kuzma, M Bálint, C Hetényi, T Bencsik Biomedicine & Pharmacotherapy 102, 912-921, 2018 | 32 | 2018 |
| Interactions of resveratrol and its metabolites (resveratrol-3-sulfate, resveratrol-3-glucuronide, and dihydroresveratrol) with serum albumin, cytochrome P450 enzymes, and OATP … M Poór, H Kaci, S Bodnárová, V Mohos, E Fliszár-Nyúl, S Kunsági-Máté, ... Biomedicine & Pharmacotherapy 151, 113136, 2022 | 29 | 2022 |
| Testing the pharmacokinetic interactions of 24 colonic flavonoid metabolites with human serum albumin and cytochrome P450 enzymes V Mohos, E Fliszár-Nyúl, B Lemli, BZ Zsidó, C Hetényi, P Mladěnka, ... Biomolecules 10 (3), 409, 2020 | 29 | 2020 |
| Exploratory and locomotor activity, learning and memory functions in somatostatin receptor subtype 4 gene-deficient mice in relation to aging and sex N Szentes, V Tékus, V Mohos, É Borbély, Z Helyes GeroScience 41, 631-641, 2019 | 28 | 2019 |
| Synthesis of spin-labelled bergamottin: A potent CYP3A4 inhibitor with antiproliferative activity BZ Zsidó, M Balog, N Erős, M Poór, V Mohos, E Fliszár-Nyúl, C Hetényi, ... International Journal of Molecular Sciences 21 (2), 508, 2020 | 26 | 2020 |
| Testing the extraction of 12 mycotoxins from aqueous solutions by insoluble beta-cyclodextrin bead polymer V Mohos, Z Faisal, E Fliszár-Nyúl, L Szente, M Poór Environmental Science and Pollution Research 29, 210-221, 2022 | 17 | 2022 |
| Interaction of silymarin components and their sulfate metabolites with human serum albumin and cytochrome P450 (2C9, 2C19, 2D6, and 3A4) enzymes Z Faisal, V Mohos, E Fliszár-Nyúl, K Valentová, K Káňová, B Lemli, ... Biomedicine & Pharmacotherapy 138, 111459, 2021 | 16 | 2021 |
| Interactions of 7, 8-dihydroxyflavone with serum albumin as well as with CYP2C9, CYP2C19, CYP3A4, and xanthine oxidase biotransformation enzymes E Fliszár-Nyúl, V Mohos, T Bencsik, B Lemli, S Kunsági-Máté, M Poór Biomolecules 9 (11), 655, 2019 | 15 | 2019 |
| Interaction of SZV 1287, a novel oxime analgesic drug candidate, and its metabolites with serum albumin E Fliszár-Nyúl, Z Faisal, V Mohos, D Derdák, B Lemli, T Kálai, C Sár, ... Journal of Molecular Liquids 333, 115945, 2021 | 13 | 2021 |
| Inhibitory effects of polyphenols and their colonic metabolites on CYP2D6 enzyme using two different substrates E Fliszár-Nyúl, V Mohos, R Csepregi, P Mladěnka, M Poór Biomedicine & Pharmacotherapy 131, 110732, 2020 | 9 | 2020 |
| The advances and limitations of the determination and applications of water structure in molecular engineering BZ Zsidó, B Bayarsaikhan, R Börzsei, V Szél, V Mohos, C Hetényi International Journal of Molecular Sciences 24 (14), 11784, 2023 | 7 | 2023 |
| Topiramate inhibits adjuvant-induced chronic orofacial inflammatory allodynia in the rat V Mohos, M Harmat, J Kun, T Aczél, BZ Zsidó, T Kitka, S Farkas, E Pintér, ... Frontiers in Pharmacology 15, 1461355, 2024 | | 2024 |
| Quercetin és Chrysin Konjugátumok Farmakokinetikai Kölcsönhatásainak in Vitro Vizsgálata VK Mohos PQDT-Global, 2021 | | 2021 |
| In vitro investigation of the pharmacokinetic interactions of quercetin and chrysin conjugates VK Mohos University of Pécs, 2021 | | 2021 |
